Trial Profile
A Randomized, Double- or Evaluator-blind, Active- and Placebo-controlled, Single Dose, Seven-arm, Crossover Dose-ranging Study of A006 in Adult Asthma Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2017
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 26 Apr 2012 New trial record